And the reduced number of BrdU+Sox2+GFAP+ RGLs and BrdU+DCX+ neuroblasts of DG induced by CRS was prevented by COS treatment (5 μM, 1 μL per side) (Fig. 3b, c). The gene discussed is GFAP; the disease is congenital rubella syndrome.